Literature DB >> 535775

Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.

J Spona, R Ulm, C Bieglmayer, P Husslein.   

Abstract

Serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin (HPRL), 17 beta-estradiol (E2) and progesterone (P) were estimated in 46 subjects with normal menstrual cycles in whom hysterectomies were performed. Estrogen (ER) and progesterone receptor (PgR) levels in endometrial samples of these patients were estimated, and histological dating of the cycle day was carried out. Similarly, hormone serum levels and ER as well as PgR were estimated in 17 patients with endometrial carcinoma. No correlation between LH, FSH, HPRL and ER as well as PgR was noted in the normal subjects. Correlation between P and ER was observed in this group. Parallel variations between E2 and PgR were recorded in the normal females. In the carcinoma group no correlations between hormone serum levels and receptor contents were found, but ER and PgR correlated with each other. Receptor levels was highest in the well-differentiated group of endometrial carcinoma. The present experiments provide a rationale for progestagen therapy of carcinoma of the endometrium.

Entities:  

Keywords:  Biology; Cancer; Comparative Studies; Diseases; Endocrine System; Endometrial Cancer; Estradiol--analysis; Estrogens; Follicle Stimulating Hormone--analysis; Gonadotropins; Gonadotropins, Pituitary; Hormone Receptors--analysis; Hormones; Luteinizing Hormone--administraction and dosage; Membrane Proteins; Neoplasms; Physiology; Pituitary Hormones; Progestational Hormones; Progesterone--analysis; Prolactin--analysis; Research Methodology; Studies

Mesh:

Substances:

Year:  1979        PMID: 535775     DOI: 10.1159/000299920

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  7 in total

1.  Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria.

Authors:  H Pickartz; R Beckmann; B Fleige; W Düe; J Gerdes; H Stein
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer.

Authors:  E Tichatschek; C C Zielinski; C Müller; P Sevelda; E Kubista; K Czerwenka; J Spona; H Wolf; M M Eibl
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

3.  The distribution of oestrogen and progesterone receptors in the human endometrial basal and functional layer during the normal menstrual cycle. An immunocytochemical study.

Authors:  M T Coppens; M A Dhont; J G De Boever; R F Serreyn; D A Vandekerckhove; H J Roels
Journal:  Histochemistry       Date:  1993-02

4.  Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy.

Authors:  R Jakesz; C Dittrich; J Hanusch; R Kolb; R Lenzhofer; K Moser; H Rainer; G Reiner; M Schemper; J Spona
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

Review 5.  The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors:  R Vihko; A Alanko; V Isomaa; A Kauppila
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

6.  Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor.

Authors:  M F Press; J A Udove; G L Greene
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

7.  [Estrogen and androgen receptors in patients with acne vulgaris (author's transl)].

Authors:  J B Schmidt; J Spona
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.